Familiarity Breeds Exempt: Why Staph Vaccines Don’t Work in Humans
July 7, 2022
UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.
Your search for “Infectious disease” returned 331 results
SDSC’s Comet Supercomputer, TSCC Available for COVID-19 Research
April 8, 2020
The San Diego Supercomputer Center at UC San Diego is providing priority access to its high-performance computer systems and other resources to researchers advancing our understanding of the virus and efforts to develop an effective vaccine in as short a time as possible.
A Novel COVID-19 Vaccine Using Modified Bacterial DNA
July 21, 2022
UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.
Quest for Edible Malarial Vaccine Leads to Other Potential Medical Uses for Algae
April 19, 2013
Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That’s the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission. In a follow up…
Cat Bacteria Treats Mouse Skin Infection, May Help You and Your Pets As Well
October 19, 2021
Researchers at UC San Diego School of Medicine identify a strain of bacteria on healthy cats that produces antibiotics against severe skin infections. The findings may soon lead to new bacteriotherapies for humans and their pets, wherein cat bacteria is applied via topical cream or spray.
A Nanomaterial Path Forward for COVID-19 Vaccine Development
July 15, 2020
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.
Unprecedented Case Series Advances Promise of Phage Therapy
June 9, 2022
An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated with bacteriophage therapy for antibiotic-resistant infections.
Two UC San Diego Biologists Named Pew Scholars
June 14, 2018
The Pew Charitable Trusts has announced that UC San Diego Biological Sciences Assistant Professors Matthew Daugherty and Enfu Hui have been selected to the 2018 class of Pew Scholars in the Biomedical Sciences. Pew also announced that Diego Alvarez and Grisel Cruz Becerra, Biological Sciences postdoctoral researchers, have been named…
Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?
July 9, 2020
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
Therapeutic Potential of Bizarre ‘Jumbo’ Viruses Tapped for $10M HHMI Emerging Pathogens Project
January 26, 2023
UC San Diego and its collaborating partners have been awarded $10 million from the Howard Hughes Medical Institute to leverage the biomedical promise of viruses known as bacteriophages as new therapeutic agents in the fight against the rising crisis of antibiotic-resistant bacterial infections.
